All posts by: Michael Zand

About Michael Zand

Gene therapy for advanced lymphoma gets FDA approval – Engadget

Continue reading

2017-10-19 NEWS

Engadget

Gene therapy for advanced lymphoma gets FDA approval
Engadget
People with advanced lymphoma now have another type of treatment to consider. The Food and Drug Administration has approved Yescarta, a cell-based gene therapy designed to treat large B-cell lymphoma created by Kite Pharma. It’s the second time the …
FDA approves 2nd gene therapy targeting non-Hodgkin lymphomasCNN
FDA Approves Another Amazing And Costly Cancer-Killing Gene TherapyForbes
FDA approves 2nd gene therapy for blood cancer, this one for aggressive lymphoma in adultsChicago Tribune
NBCNews.com –WebMD –Reuters –FDA.gov
all 98 news articles »
Continue reading

2017-10-19 NEWS

Engadget

Gene therapy for advanced lymphoma gets FDA approval
Engadget
People with advanced lymphoma now have another type of treatment to consider. The Food and Drug Administration has approved Yescarta, a cell-based gene therapy designed to treat large B-cell lymphoma created by Kite Pharma. It’s the second time the …
FDA approves 2nd gene therapy targeting non-Hodgkin lymphomasCNN
FDA Approves Another Amazing And Costly Cancer-Killing Gene TherapyForbes
FDA approves 2nd gene therapy for blood cancer, this one for aggressive lymphoma in adultsChicago Tribune
NBCNews.com –WebMD –Reuters –FDA.gov
all 98 news articles »
Continue reading

2017-10-19 NEWS

New encapsulation device could boost stem cell treatment results in type 1 diabetes
Diabetes.co.uk
The new device will be integrated into Encellin’s existing implantable cell delivery system, so far only tested in animals, for upcoming human research on stem cell-derived therapies in type 1 diabetes. Encapsulation and protection of islet cells